Amarin Message Board


What's the Strategy in the U.S. for Neovasc's Reducer?

1 month ago

Neovasc (Nasdaq: NVCN) is a medical device company primarily known for Reducer, which is a minimally invasive device that helps treat patients with refractory angina. The device has been approved in Europe

Amarin Suspends Sales Reps Because of Coronavirus

2 weeks ago

“As a company focused for more than a decade on fighting cardiovascular disease, which in the United States alone results in one stroke, heart attack or death every 14 seconds, we are determined to do our part to protect public health and the health of our many valued employees,” said John Thero, president and chief executive officer of Amarin. “We have developed a roadmap of remote working activities for us to continue to help many patients with persistent cardiovascular risk, including u…

Amarin Stock AMRN

3 weeks ago

and a run to $29 is possible with a favorable ruling.

Vascepa Script Numbers

1 month ago

Are those week-to-week numbers considered good growth at this stage of the game with the new label?

Amarin Patents

2 months ago

Amarin has done a great job increasing their patents...

That's 3 patents granted already in 2020.

What Happens if Amarin Loses the Patent Trial?

2 months ago

I've read conflicting reports with some saying an Amarin victory in the patent trial is a sure thing and then there are those saying it isn't and there is a real possibility we lose the case. What happens if Amarin loses? Will there be major layoffs, stock cut in half, and revenue projections cut in half as well?

Amarin 2020 NSM

2 months ago

"Our Time, Their Future" followed with a mic drop. Then he left for San Francisco.

Amarin Commercial Expansion

2 months ago

JT elaborated on this in the breakout at JPM -

On salesforce expansion: "I think there's still some question if 800 is the ideal number or not. It may be larger than that," Thero says. Adds it's possible for incremental expansion in 2020 if sales reps pay for themselves. H/T BioPharmaDive

Amarin Buyout

2 months ago

Thero even talked about not wanting to get a European partner yet, calling it pre-mature, which is interesting.

Amarin JP Morgan Healthcare Conference

3 months ago

What's more likely to happen with Amarin at the JP Morgan Healthcare Conference?


A. Amarin's patent infringement case settles during the week of the meeting

B. Amarin gets acquired for > $20 billion

C. JT skips his presentation to hang out with the sea lions at Fisherman's Wharf

D. All of the above

Will the FDA Approval Expanded Label for Vascepa?

3 months ago

Here is the Matinas CEO in an interview post Vascepa label expansion, saying everything that JT meant to say on CNBC but couldn't articulate properly.


Loading...